Showing results (41-50 of 112) with videos related to
Sort By:
Pageof 12
Advances in Radiation Oncology|May 1, 2023
Improving Communication of Peer-Review Conference Outcomes: A Practical ExperienceJoseph A Jones, Michael H Soike, D Hunter Boggs, et al.Mayo Clinic Proceedings|August 11, 2004
Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosisAdam Svobodník, Ping Yang, Paul J Novotny, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 2004
Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expressionJames A Bonner, Donald J Buchsbaum, Suzanne M Russo, et al.The Annals of Thoracic Surgery|November 25, 2005
Patterns of surgical care of lung cancer patientsAlex G Little, Valerie W Rusch, James A Bonner, et al.The Oncologist|May 21, 2017
p16, HPV, and Cetuximab: What Is the Evidence?James A Bonner, Ricard Mesia, Jordi Giralt, et al.Biorxiv : the Preprint Server for Biology|April 25, 2024
Gfi1 controls the formation of effector CD8 T cells during chronic infection and cancerOluwagbemiga A Ojo, Hongxing Shen, Jennifer T Ingram, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2015
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without CetuximabDavid I Rosenthal, Paul M Harari, Jordi Giralt, et al.International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiationDonald J Buchsbaum, James A Bonner, William E Grizzle, et al.Anti-Cancer Drugs|December 1, 2005
Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I studyMichael C Dobelbower, Suzanne M Russo, Kevin P Raisch, et al.Nature Communications|May 15, 2025
Gfi1 controls the formation of effector-like CD8<sup>+</sup> T cells during chronic infection and cancerOluwagbemiga A Ojo, Hongxing Shen, Jennifer T Ingram, et al.Pageof 12